Skip to content
Homepage
Treatment Guide

POTS Treatment

Emerging evidence base
Written by Health Writer & Ops
Edited by Health and Wellness Writer and Registered Nutritionist
Reviewed by Expert in Regenerative & Longevity Medicine, Bioidentical Hormone Therapy, and Pediatric Precision Health

Regenerative approaches to postural orthostatic tachycardia syndrome that target the underlying drivers of the condition.

How does regenerative POTS treatment work?

POTS is a condition that causes your heart to beat faster than normal when you move from lying or sitting to standing up. Your heart and blood pressure are under the control of your autonomic nervous system. Normally, the autonomic nervous system tightens blood vessels and steadies the heart rate when you stand up, but in POTS, this reflex (called the baroreflex) doesn’t activate properly. Blood pools in your legs instead of flowing to your brain, and your heart races to compensate. That racing heart is the tachycardia in the name, and the dizziness and fog are orthostatic intolerance, symptoms triggered by being upright.

Regenerative and functional medicine approaches to POTS focus on what might have caused this dysregulation in the first place. Common drivers include low blood volume, a recent viral illness that has left the immune system misbehaving, physical deconditioning, and connective tissue that lets blood pool too easily. Addressing these factors can bring improvements over time.

What types of POTS are they used for?

  • Hyperadrenergic POTS: This is POTS associated with elevated levels of norepinephrine.

  • Neuropathic POTS: POTS associated with damage to the nerve fibers that constrict blood vessels in the legs and abdomen.

  • Post-viral POTS, including Long COVID.

  • POTS with Ehlers-Danlos syndrome or hypermobility. These conditions affect connective tissue.

  • POTS that overlaps with excessive mast cell activation.

Satish Raj, MD, from the University of Calgary, emphasizes that POTS has at least three overlapping mechanisms, and matching the treatment to the mechanism is what makes the difference.

What to expect during treatment

A good workup comes first. The clinician measures your heart rate and blood pressure lying down and then standing, and may also use a tilt table test, during which you are strapped upright on a motorized table while your vitals are tracked. An increase in heart rate of at least 30 beats per minute on standing without a drop in blood pressure is the diagnostic line. The workup also looks for subtype clues and screens for triggers like a recent infection.

Treatment plans are designed to work over months rather than days, to allow your body time to adapt. Exercise reconditioning often starts lying down or on a recumbent bike to avoid the upright trigger, then progresses slowly. Measures to improve blood volume and circulation can help within weeks, and many people notice they can stand for longer and experience less dizziness before they notice a lower resting heart rate.

The Regenerative Medicine Approach (in depth)

Functional and regenerative medicine view POTS as a downstream effect of a deeper underlying cause. Three overlapping subtypes are recognized:

  • Hyperadrenergic POTS is driven by surges of norepinephrine, the body's main stress and blood-vessel-tightening hormone, and often comes with high standing blood pressure and tremor.

  • Neuropathic POTS involves small-fiber neuropathy, damage to the tiny nerves that tell leg blood vessels to constrict, meaning blood pools instead.

  • Nearly everyone with POTS also has some degree of hypovolemia, a lower-than-normal blood volume.

Two patterns commonly sit alongside POTS. Roughly a third of patients have Ehlers-Danlos syndrome or hypermobility, where lax connective tissue lets veins stretch and pool. Many also have mast cell activation syndrome (MCAS), where immune cells release too much histamine and inflammatory chemicals. Deconditioning, the loss of fitness from being too symptomatic to move, compounds all of it.

Treatments That May Help

POTS responds best to a layered plan rather than a single fix. The approaches below range from foundational lifestyle measures, which carry the strongest evidence and do most of the long-term work, to targeted treatments for specific subtypes. Most people use several together, guided by which subtype and which triggers are in play.

Foundational measures

It’s helpful to sleep with the head of the bed raised to boost blood volume overnight, to stay cool and avoid overheating, and to pace energy across the day. These measures help reduce the load on an already strained system.

Exercise reconditioning

Structured exercise rebuilds the heart's stroke volume and retrains the baroreflex. This intervention has the strongest trial evidence of any POTS treatment. Protocols like the Levine and CHOP programs start with recumbent or supine rowing, cycling, or swimming, to sidestep the upright trigger, then progress gradually over three to six months. Exercise may feel counterintuitive when simply standing up is enough to trigger unpleasant symptoms but this is why personalized guidance matters. The exercise plan needs to be tailored to your ability and adjusted to match your progress.

Salt and fluid loading

Because low blood volume is near-universal in POTS, expanding it non-pharmacologically helps most patients. Clinicians often recommend 8 to 10 grams of salt per day (about 3.2 to 4 grams of sodium) and 2.5 to 3 liters of fluid spread across the day rather than taken all at once. It is simple and low-cost. Sodium loading isn’t appropriate for everyone. Talk it through with your clinician first if you have high blood pressure, heart failure, or kidney disease.

Compression garments

Waist-high compression garments, typically 30 to 40 mmHg, physically limit how much blood pools in the legs and abdomen when you stand. This leaves more circulating blood to reach the brain and means the heart doesn’t have to work as hard to pump it there. The garments work immediately and pair well with the volume measures above.

Vagal tone work

Practices like heart-rate-variability biofeedback and slow-paced breathing strengthen parasympathetic tone, the calming, recovery side of the autonomic nervous system. The goal is to shift a system stuck in overdrive back toward balance. The evidence here is early-stage, but the practices are low-risk and cost little.

Low-dose naltrexone

Low-dose naltrexone (LDN) is a medication prescribed off-label at a fraction of its standard dose to calm immune-driven inflammation in the nervous system. Some clinicians use it for POTS associated with autoimmunity or POTS that overlaps with chronic fatigue, particularly when pain is part of the picture. The evidence is limited to case series and chart reviews so far.

IVIG for autoimmune POTS

Intravenous immunoglobulin (IVIG) is an infusion of pooled donor antibodies that can dampen an autoimmune attack. It is reserved for the small group of POTS patients with documented autoimmune markers, not POTS in general. It is expensive, time-intensive, and best considered only after lifestyle and standard measures have been tried.

Treating triggers

When a clear trigger is present, addressing it directly can change the trajectory. That might mean antiviral or immune support for post-viral cases, mast cell stabilization for MCAS overlap, or managing the joint and connective tissue side of Ehlers-Danlos. The aim is to remove what keeps the autonomic nervous system dysregulated.

What the Evidence Supports

The clearest evidence is for exercise reconditioning. A controlled training study found that three months of structured exercise increased stroke volume and lowered heart rate during exertion in people with POTS, with cardiac function normalizing as fitness improved (Shibata et al., 2012). Reviews of non-pharmacological care reach the same conclusion, ranking graded exercise as the most effective single intervention (Fu & Levine, 2018). A pragmatic trial confirmed real-world benefit (Gibbons et al., 2021).

However, although structured exercise treatment has the most supportive evidence, it is hard to sustain. Real-world programs report low adherence because the early weeks are difficult (Landry et al., 2020).

Volume expansion has good short-term data. Intravenous saline raised stroke volume and cardiac output in POTS patients, who were measurably hypovolemic (Figueroa et al., 2014). The subtype framework itself, matching treatment to neuropathic, hyperadrenergic, or hypovolemic mechanisms, is well-described in the clinical literature (Mar & Raj, 2020).

Post-viral POTS is now well-documented, with case series and cohort data showing POTS emerging after COVID-19 in previously healthy people (Blitshteyn & Whitelaw, 2021; Seeley et al., 2023).

Where the Evidence Is Limited

Several widely discussed treatments rest on thin ground. The one randomized trial of IVIG for autoimmune POTS, iSTAND, found no significant difference from albumin infusion, though both groups improved (Vernino et al., 2024).

Low-dose naltrexone (LDN) has no controlled POTS trials at all; the support is chart reviews and case series, and one analysis found no statistically significant change in autonomic symptom scores (Zapata et al., 2025).

Salt and fluid loading, despite being standard advice, lacks long-term randomized evidence and rests mostly on short-term physiology.

Combining Treatments

In practice, these approaches are layered rather than used separately. The usual base is volume expansion and compression, which raises circulating blood and curbs blood pooling. Combining these measures with exercise reconditioning can drive sustainable, long-lasting change.

When used, conventional medications can help make standing tolerable enough to enable movement, while the benefits of exercise reconditioning slowly take hold. Trigger-directed therapy, antiviral support, mast cell stabilization, or connective tissue care is added for the patients with the relevant POTS subtypes.

Finding the Right Provider

POTS is often missed or dismissed, so finding the right provider really matters. Look for an autonomic specialist, a cardiologist, or a neurologist who regularly treats POTS, rather than a generalist seeing it for the first time.

Good questions to ask include how will you work out my subtype? What does the exercise protocol look like, and how does it start? Will you screen for triggers like a past infection, hypermobility, or mast cell issues?

Be cautious of any provider who frames POTS as "just anxiety," who dismisses exercise rather than prescribing a graded protocol, or who pushes IVIG without first running antibody testing. POTS is treatable, but only when it is taken seriously as an autonomic disorder.

Takeaway

POTS is a defined autonomic disorder with objective diagnostic criteria, and it is treatable. The treatments that can improve the condition over the long term are graded exercise reconditioning, volume expansion through salt and fluid, and compression. Medications and regenerative options like LDN and IVIG have a narrower role, mostly for specific subtypes and autoimmune cases.

If you are new to this journey, start by getting a clear diagnosis and subtype workup. Find a clinician who can personally guide the exercise protocol, and track standing tolerance and daily function as your progress markers. For the wider context of autonomic dysfunction, our broader guide to dysautonomia is a good next read.

If you’re looking for a provider, you can browse vetted POTS treatment clinics across the U.S. in our directory.

Frequently asked questions

The questions patients ask most before starting POTS Treatment.

Most plans start with increasing salt and fluid, wearing waist-high compression garments, and a graded exercise program that begins lying down or on a recumbent bike. Conventional medications may be added to make standing tolerable while you work on the exercise reconditioning. For specific subtypes, trigger-directed treatment is layered on top.

Initial signs of progress include being able to stand for longer without feeling dizzy, less brain fog, and better, steadier energy across the day. A lower resting and standing heart rate often follows later. Tracking how long you can be upright and what you can do in a day is more useful than watching your pulse alone.

Yes, when it is done as part of a personalized, supervised protocol. POTS-specific programs start with recumbent or supine exercise precisely to avoid the upright trigger, then progress slowly. The caution is against being told to "just exercise more" without that structure, which can set you back.

Yes, it can. A meaningful number of adolescents and some post-viral cases improve substantially or recover. For others it is a long-term condition that can still be well-managed. POTS is not necessarily a permanent diagnosis, and even when it persists, the right treatment can restore a great deal of function.

References

Blitshteyn, S., & Whitelaw, S. (2021). Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: A case series of 20 patients. Immunologic Research, 69(2), 205–211.

Figueroa, R. A., Arnold, A. C., Nwazue, V. C., Okamoto, L. E., Paranjape, S. Y., Black, B. K., Diedrich, A., Robertson, D., Biaggioni, I., Raj, S. R., & Gamboa, A. (2014). Acute volume loading and exercise capacity in postural tachycardia syndrome. Journal of Applied Physiology, 117(6), 663–668.

Fu, Q., & Levine, B. D. (2018). Exercise and non-pharmacological treatment of POTS. Autonomic Neuroscience: Basic & Clinical, 215, 20–27.

Gibbons, C. H., Silva, G., & Freeman, R. (2021). Cardiovascular exercise as a treatment for postural orthostatic tachycardia syndrome: A pragmatic treatment trial. Heart Rhythm, 18(8), 1361–1368.

Landry, M., Harvey, P., Osuntokun, T., Childerhose, D., Delos-Reyes, F., Fong, M., & Price, J. (2020). Postural orthostatic tachycardia syndrome (POTS) and cardiac rehabilitation: Clinical successes and challenges. Medicine & Science in Sports & Exercise, 52(7S), 1043\.

Mar, P. L., & Raj, S. R. (2020). Postural orthostatic tachycardia syndrome: Mechanisms and new therapies. Annual Review of Medicine, 71, 235–248.

Seeley, M.-C., Gallagher, C., Ong, E., Langdon, A., Chieng, J., Bailey, D., Page, A., Lim, H. S., & Lau, D. (2023). High incidence of autonomic dysfunction and postural orthostatic tachycardia syndrome in patients with long-COVID: Implications for management and healthcare planning. American Journal of Medicine, 136(12), 1217–1223.

Shibata, S., Fu, Q., Bivens, T. B., Hastings, J., Wang, W., & Levine, B. D. (2012). Short-term exercise training improves the cardiovascular response to exercise in the postural orthostatic tachycardia syndrome. Journal of Physiology, 590(15), 3495–3505.

Vernino, S., Hopkins, S., Bryarly, M., Hernandez, R. S., & Salter, A. (2024). Randomized controlled trial of intravenous immunoglobulin for autoimmune postural orthostatic tachycardia syndrome (iSTAND). Clinical Autonomic Research, 34(1), 153–163.

Zapata, N., Georgiadi, E., Cantrell, C., Rilinger, R. G., Levine, M., & Wilson, R. (2025). Low-dose naltrexone for managing pain and autonomic symptoms in patients with dysautonomia. Cureus, 17(5), e86538.

About this article

Written by

Lucinda is a writer and researcher with a deep personal interest in health optimization, shaped by more than 12 years of managing chronic health challenges w...

Edited by

Sally Duffin, MBANT, rCNHC

Sally Duffin is a health writer, speaker, Registered Nutritionist, and published author specialising in perimenopause and midlife women's health. She qu...

Medically reviewed by

Dr. Bronwyn Holmes, MD, FAARFM

Dr. Bronwyn Holmes is a board-certified physician and the founder of Bronwyn MD, a private concierge practice with origins in New York City, now based in Los...

Ready to find a clinic that offers POTS Treatment?

Browse 0 vetted clinics offering POTS Treatment across the US. All NPI-verified, physician-confirmed, and OIG clear.